ADMA · Adma Biologics, Inc.
$9.47
+0.06 (+0.64%)
At close · Aug 14
Market Cap
$2.12B
Shares
223.98M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-10 | Tade Brad L. | Former Officer | 50,026 | 2026-03-10 | Fidelity Brokerage Services, LLC |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Officer | 10,096 | 2026-03-09 | Fidelity Brokerage Services, LLC |
| 2026-02-17 | Grossman Adam S. | Director, Officer | 84,000 | 2026-02-17 | Fidelity Brokerage Services, LLC |
| 2025-10-24 | Grossman Adam S. | Director and Officer | 63,000 | 2025-10-24 | Fidelity Brokerage Services, LLC |
| 2025-07-15 | Grossman Adam S | Director and Officer | 63,000 | 2025-07-15 | Fidelity Brokerage Services, LLC |
| 2025-06-12 | ELMS STEVE | Director | 425,621 | 2025-06-12 | Charles Schwab |
| 2025-06-09 | Grossman Jerrold B | Director | 10,000 | 2025-06-09 | Fidelity Brokerage Services, LLC |
| 2025-06-04 | Lawrence P Guiheen Rev Tr DTD 09/20/19 | Director | 20,000 | 2025-06-04 | UBS Financial Services Inc |
| 2025-05-21 | Guiheen Lawrence P. | Director | 9,000 | 2025-05-21 | Fidelity Brokerage Services, LLC |
| 2025-03-19 | Grossman Adam S | Director and Officer | 84,000 | 2025-03-19 | Fidelity Brokerage Services, LLC |
| 2024-11-22 | Grossman Adam S | Director and Officer | 48,967 | 2024-11-22 | Raymond James & Associates, Inc. |
| 2024-11-22 | Tade Brad L. | Officer | 15,000 | 2024-11-22 | Raymond James & Associates, Inc. |
| 2024-09-09 | Guiheen Lawrence P. | Director | 9,000 | 2024-09-09 | Raymond James & Associates, Inc. |
| 2024-08-30 | Kestenberg-Messina Kaitlin M. | Officer | 24,150 | 2024-08-30 | Raymond James & Associates, Inc. |
| 2024-08-29 | Grossman Jerrold B | Director | 136,861 | 2024-08-29 | Raymond James & Associates, Inc. |
| 2024-08-26 | Grossman Adam S | Officer, Director | 626,245 | 2024-08-26 | Raymond James & Associates, Inc. |
| 2024-06-14 | Grossman Adam S | Officer, Director | 500,000 | 2024-06-14 | Raymond James & Associates, Inc. |
| 2024-03-13 | Aisling Capital II LP | Affiliate | 1,500,000 | 2024-03-13 | Merrill Lynch |
| 2023-08-22 | Bryant Fong | Board Member | 1,433,304 | 2023-08-22 | J.P. Morgan Securities LLC |
| 2023-08-14 | Grossman Adam S | Officer - President and CEO | 2,120,459 | 2023-08-15 | Raymond James & Associates, Inc. |
| 2023-08-14 | LENZ BRIAN | OFFICER-CFO | 1,020,840 | 2023-08-15 | Raymond James & Associates, Inc. |
Showing 1–21 of 21 filings
Key facts
CIK
1368514
CUSIP
000899104
13F (30d)
292 filings
288 filers
Visit website
Investor relations